BR9611033A - Processes for treating h.pylori infection in a mammal and for converting the coccoid form of h. pylori in culture in the spiral form and the spiral form of h.pylori in culture in the coccoid form, pharmaceutical formulation and use of an agent capable of inducing the coccoid form of h.pylori - Google Patents

Processes for treating h.pylori infection in a mammal and for converting the coccoid form of h. pylori in culture in the spiral form and the spiral form of h.pylori in culture in the coccoid form, pharmaceutical formulation and use of an agent capable of inducing the coccoid form of h.pylori

Info

Publication number
BR9611033A
BR9611033A BR9611033-3A BR9611033A BR9611033A BR 9611033 A BR9611033 A BR 9611033A BR 9611033 A BR9611033 A BR 9611033A BR 9611033 A BR9611033 A BR 9611033A
Authority
BR
Brazil
Prior art keywords
pylori
coccoid
culture
spiral
processes
Prior art date
Application number
BR9611033-3A
Other languages
Portuguese (pt)
Inventor
Bow Ho
Original Assignee
Cortecs International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9520585.2A external-priority patent/GB9520585D0/en
Application filed by Cortecs International Limited filed Critical Cortecs International Limited
Publication of BR9611033A publication Critical patent/BR9611033A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Abstract

"FORMULAçãO FARMACêUTICA, USO DE UM AGENTE CAPAZ DE INDUZIR A FORMA COCCóIDE DE H. PYLORI, E, PROCESSO PARA CONVERTER A FORMA COCCóIDE DE H. PYLORI à FORMA EM ESPIRAL". A invenção provê novas terapias para o tratamento de infecções por H. pylori, assim como formulações farmacêuticas para uso nestes processos."PHARMACEUTICAL FORMULATION, USE OF AN AGENT ABLE TO INDUCT THE COCCOID FORM OF H. PYLORI, AND, PROCESS TO CONVERT THE COCCOID FORM OF H. PYLORI TO SPIRAL FORM". The invention provides new therapies for the treatment of H. pylori infections, as well as pharmaceutical formulations for use in these processes.

BR9611033-3A 1995-10-09 1996-10-08 Processes for treating h.pylori infection in a mammal and for converting the coccoid form of h. pylori in culture in the spiral form and the spiral form of h.pylori in culture in the coccoid form, pharmaceutical formulation and use of an agent capable of inducing the coccoid form of h.pylori BR9611033A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9520585.2A GB9520585D0 (en) 1995-10-09 1995-10-09 Therapeutic method
US1588296P 1996-04-19 1996-04-19
PCT/GB1996/002456 WO1997013527A1 (en) 1995-10-09 1996-10-08 Treatments of helicobacter pylori infections

Publications (1)

Publication Number Publication Date
BR9611033A true BR9611033A (en) 1999-12-28

Family

ID=26307915

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611033-3A BR9611033A (en) 1995-10-09 1996-10-08 Processes for treating h.pylori infection in a mammal and for converting the coccoid form of h. pylori in culture in the spiral form and the spiral form of h.pylori in culture in the coccoid form, pharmaceutical formulation and use of an agent capable of inducing the coccoid form of h.pylori

Country Status (9)

Country Link
EP (1) EP0862458A1 (en)
JP (1) JPH11514998A (en)
KR (1) KR19990064104A (en)
CN (1) CN1201395A (en)
AU (1) AU7141096A (en)
BR (1) BR9611033A (en)
MX (1) MX9802809A (en)
NO (1) NO981594L (en)
WO (1) WO1997013527A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7939079B2 (en) 2006-11-14 2011-05-10 Universiteit Gent Helicobacter species and cultivation thereof
CN101558150A (en) * 2006-11-14 2009-10-14 根特大学 In vitro cultivation of helicobacter species
JP5145700B2 (en) * 2006-11-20 2013-02-20 学校法人慶應義塾 Career

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6290962B1 (en) * 1992-11-03 2001-09-18 Oravax, Inc. Urease-based vaccine and treatment for helicobacter infection

Also Published As

Publication number Publication date
EP0862458A1 (en) 1998-09-09
MX9802809A (en) 1998-11-29
NO981594L (en) 1998-06-03
WO1997013527A1 (en) 1997-04-17
AU7141096A (en) 1997-04-30
KR19990064104A (en) 1999-07-26
NO981594D0 (en) 1998-04-07
CN1201395A (en) 1998-12-09
JPH11514998A (en) 1999-12-21

Similar Documents

Publication Publication Date Title
PT956858E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILS FOR THE TREATMENT OF VAGINAL INFECTIONS
BR9605111A (en) Oral pharmaceutical dosage formulation process for the manufacture of a fixed dosage formulation method for the treatment of disorders with helicobacter pylori infections in mammals and humans and use of a dosage formulation
ES2160707T3 (en) COMPOSITIONS THAT INCLUDE DETERIORATING AGENTS OF DNA AND P53.
BR9910570A (en) Apparatus for the treatment of tissue and / or joint disorders
BR9407869A (en) Combination of pharmaceutical composition and process for the treatment of osteoporosis
ES2150496T3 (en) CONDENSED CYCLLOALKYLIMIDAZOPYRIDIDS.
BR9808812A (en) Composition comprising crystalline, finely divided budesonide particles
FI956014A (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
BRPI0408655A (en) formulations comprising an active agent and cocoa powder and their use
BR0215404A (en) process and device for reducing therapeutic dosage
BR9506581A (en) Compound pharmaceutical composition use of the process compound for the prophylaxis or treatment of a clinical condition in a manifer for example a human and for the preparation of a compound and intermediate compound
BR0010983A (en) Preparations for the application of anti-inflammatory agents
BR0109164A (en) Monoclonal antibodies to the human LDL receptor, production and use thereof
BR9611033A (en) Processes for treating h.pylori infection in a mammal and for converting the coccoid form of h. pylori in culture in the spiral form and the spiral form of h.pylori in culture in the coccoid form, pharmaceutical formulation and use of an agent capable of inducing the coccoid form of h.pylori
BR9105260A (en) COMPOSITION FOR TOPICAL APPLICATION ON THE SURFACE OF THE HUMAN BODY, PROCESSES FOR THE COSMETIC TREATMENT OF THE HUMAN BODY AND FOR THE PRODUCTION OF A COMPOSITION
BR0206775A (en) Use of a drug to treat an HIV-infected individual by combining immunization with structured interruption of antiretroviral treatment
NO922136L (en) USE OF GIBBERELLINES FOR TREATMENT OF PROSTATITIES AND PSORIASIS
BR9509925A (en) Composition and use of the composition to prevent or treat HIV-1 infection
DE69739482D1 (en) THERAPEUTIC FORMULATIONS CONTAINING SNAKE AND / OR INSECTICIDE TO THE PROPHYLAXIS AND THERAPY OF NEOPLASMS
BR9508021A (en) Pharmaceutical composition for the treatment of schizophrenic disorders, use of an immunosuppressive agent, and treatment process of a schizophrenic patient
FI951655A0 (en) Treatment of H.pylori infections
CL2004001291A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES CARBOCICLIC AND HETEROCICLIC COMPOUNDS; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF INFLUENZA INFECTION.
ITMI941134A0 (en) ANTIGEN CAPABLE OF CONFERRING PROTECTIVE IMMUNITY AGAINST HELMINTH INFECTIONS IN HUMANS AND ANIMALS AND VACCINATION PROCESS FOR APPLICATION IN THE IMMUNOPROPHYLAXY OF HELMINTH DISEASES OF MEDICAL AND VETERINARY INTEREST
DE60136777D1 (en) WATER-HARDENING FILM-FORMING PREPARATIONS AND NAIL-CARPET PRODUCTS AND NAIL CARE PROCESSES THEREOF
PT89582B (en) PROCESS FOR THE PREPARATION OF UTIAL BETA-LACTAMIC ANTIBIOTICS AS MEDICINES

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law